SCHEMBL5887499

SCHEMBL5887499

COc1cccc(C2=C(c3ccc(C)cc3)C(C(F)(F)F)=CC[CH]2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH3 Q96Q83 1/20 0.41
PGR P06401 1/20 0.40
AR P10275 1/20 0.40
KDM4E B2RXH2 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 2/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MAPT P10636 1/20 0.36
HIF1A Q16665 1/20 0.36
ACHE P22303 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887149 0.86 AR (0.38) ARL3MBTL1HSD17B1HSD17B2
SCHEMBL5887580 0.83 ESR2 (0.35) PGRSMN1; SMN2HSD17B1HSD17B2
SCHEMBL5887285 0.83 ALKBH3 (0.44) ALKBH3KDM4ESMN1; SMN2TDP1NPSR1
SCHEMBL6047660 0.73 ALDH1A1 (0.40) SMN1; SMN2TDP1NPSR1NPC1RAB9A
SCHEMBL5887353 0.72 MEN1 (0.35) ALKBH3KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL5887498 0.72 HSD11B1 (0.34) ARHPGDCYP2C9CYP2C19HSD17B10
SCHEMBL5887288 0.72 ALDH1A3 (0.41) KDM4ESMN1; SMN2ALDH1A1L3MBTL1MAOB
SCHEMBL1047258 0.69 ALKBH3 (0.65) ALKBH3KDM4ESMN1; SMN2TDP1NPSR1
SCHEMBL25873212 0.69 ALKBH3 (0.65) ALKBH3KDM4ESMN1; SMN2TDP1NPSR1
SCHEMBL5887105 0.69 ESR2 (0.35) SMN1; SMN2NPC1MAPTTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed